Prevalence of ocular toxoplasmosis among people living with HIV: a systematic review and meta-analysis

References

• Kalogeropoulos D, Sakkas H, Mohammed B et al. Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int. Ophthalmol. 42(1), 295–321 (2022).
   PubMed Web of Science ®Google Scholar
• Garweg J. Ocular toxoplasmosis: an update. Klin. Monbl Augenheilkd 233(4), 534–539 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang K, Lin G, Han Y, Li J. Serological diagnosis of toxoplasmosis and standardization. Clin. Chim. Acta 461, 83–89 (2016).
   PubMed Web of Science ®Google Scholar
• Butler NJ, Furtado JM, Winthrop KL, Smith JR. Ocular toxoplasmosis II: clinical features, pathology and management. Clin. Exp. Ophthalmol. 41(1), 95–108 (2013).
   PubMed Web of Science ®Google Scholar
• Fabiani S, Caroselli C, Menchini M et al. Ocular toxoplasmosis, an overview focusing on clinical aspects. Acta Trop. 225, 106180 (2022).
   PubMed Web of Science ®Google Scholar
• Justiz Vaillant AA, Naik R. HIV-1-associated opportunistic infections (2023). www.ncbi.nlm.nih.gov/books/NBK539787/
   Google Scholar
• Kantzanou M, Karalexi MA, Theodoridou K et al. Prevalence of visceral leishmaniasis among people with HIV: a systematic review and meta-analysis. Eur. J. Clin. Microbiol. Infect. Dis. 42(1), 1–12 (2023).
   PubMed Web of Science ®Google Scholar
• Feroze KB, Wang J. Ocular manifestations of HIV (2023). www.ncbi.nlm.nih.gov/books/NBK441926/
   Google Scholar
• CDC. Parasites – toxoplasmosis (Toxoplasma infection) (2023). www.cdc.gov/parasites/toxoplasmosis/index.html
   Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).
   PubMed Web of Science ®Google Scholar
• Zotero. Your personal research assistant. www.zotero.org
   Google Scholar
• National Heart, Lung and Blood Institute. Study quality assessment tools (2021). www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
   Google Scholar
• Posit Software. RStudio Desktop (2023). https://posit.co/download/rstudio-desktop/
   Google Scholar
• Viechtbauer W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36(3), 1–48 (2010).
   Web of Science ®Google Scholar
• Miller JJ. The inverse of the Freeman–Tukey double arcsine transformation. Am. Stat. 32(4), 138 (1978).
   Web of Science ®Google Scholar
• Viechtbauer W, Cheung MW-L. Outlier and influence diagnostics for meta-analysis. Res. Synth. Methods 1(2), 112–125 (2010).
   PubMed Web of Science ®Google Scholar
• The Cochrane Collaboration. 9.6.5.1 ensure that there are adequate studies to justify subgroup analyses and meta-regressions. https://handbook-5-1.cochrane.org/chapter_9/9_6_5_1_ensure_that_there_are_adequate_studies_to_justify.htm
   Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109), 629–634 (1997).
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4), 1088–1101 (1994).
   PubMed Web of Science ®Google Scholar
• Barker TH, Migliavaca CB, Stein C et al. Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med. Res. Methodol. 21(1), 189 (2021).
   PubMed Web of Science ®Google Scholar
• Saadouli D, Ammari L, Ben Mansour K et al. Ocular manifestations of people living with HIV in Tunisia. South Afr. J. HIV Med. 22(1), 1–5 (2021).
   Web of Science ®Google Scholar
• E J-Y, Wang Z, Ssekasanvu J et al. Visual impairment and eye diseases in HIV-infected people in the antiretroviral therapy (ART) era in Rakai, Uganda. Ophthalmic Epidemiol. 28(1), 63–69 (2021).
   PubMed Web of Science ®Google Scholar
• Arora R, Sandhu N, Dokania P, Subramanian A. Ocular manifestations in patients of HIV (human immunodeficiency virus) infection on combined anti-retroviral therapy (CART). Ocul. Immunol. Inflamm. 30(6), 1399–1407 (2022).
   PubMed Web of Science ®Google Scholar
• Rekha KR. Evaluation of correlation between ocular manifestations with CD4+ count in HIV patients: a cross-sectional study. HIV AIDS Rev. 20(4), 264–269 (2021).
   Web of Science ®Google Scholar
• Saini N, Hasija S, Kaur P, Kaur M, Pathania V, Singh A. Study of prevalence of ocular manifestations in HIV positive patients. Nepal. J. Ophthalmol. 11(1), 11–18 (2019).
   PubMed Web of Science ®Google Scholar
• Linzerová D, Stepanov A, Němčanský J. Ocular manifestations in patients with HIV infection. Cesk. Slov. Oftalmol. 74(6), 234–239 (2018).
   Google Scholar
• Abu EK, Abokyi S, Obiri-Yeboah D et al. Retinal microvasculopathy is common in HIV/AIDS patients: a cross-sectional study at the Cape Coast Teaching Hospital, Ghana. J. Ophthalmol. 2016, 1–6 (2016).
   Web of Science ®Google Scholar
• Xavier GA, Cademartori BG, Cunha Filho NAD, Farias NADR. Evaluation of seroepidemiological toxoplasmosis in HIV/AIDS patients in the south of Brazil. Rev. Inst. Med. Trop. Sao Paulo 55(1), 25–30 (2013).
   PubMed Web of Science ®Google Scholar
• Gangaputra S, Drye L, Vaidya V et al. Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome. Am. J. Ophthalmol. 155(2), 206–212.e5 (2013).
   PubMed Web of Science ®Google Scholar
• Luo J, Jing D, Kozak I et al. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in central South China. Ophthalmic Epidemiol. 20(3), 170–175 (2013).
   PubMed Web of Science ®Google Scholar
• Sudharshan S, Kaleemunnisha S, Banu AA et al. Ocular lesions in 1,000 consecutive HIV-positive patients in India: a long-term study. J. Ophthalmic Inflamm. Infect. 3(1), 2 (2013).
   PubMedGoogle Scholar
• Bekele S, Gelaw Y, Tessema F. Ocular manifestation of HIV/AIDS and correlation with CD4+ cells count among adult HIV/AIDS patients in Jimma town, Ethiopia: a cross sectional study. BMC Ophthalmol. 13(1), 20 (2013).
   PubMedGoogle Scholar
• Abdollahi A, Mohraz M, Rasoulinejad M et al. Retinitis due to opportunistic infections in Iranian HIV infected patients. Acta Med. Iran. 51(10), 711–714 (2013).
   PubMedGoogle Scholar
• Omolase C, Komolafe O, Ayodeji O et al. Ocular manifestations in HIV-AIDS patients in a Nigerian community. S. Afr. Fam. Pract. 54(5), 455–458 (2012).
   Google Scholar
• Kaleem MA, Ramsahai S, Del Fierro K et al. Ocular findings in human immunodeficiency virus patients in Washington, DC. Int. Ophthalmol. 32(2), 145–151 (2012).
   PubMed Web of Science ®Google Scholar
• Acharya PK, Venugopal KC, Karimsab DP et al. Ocular manifestations in patients with HIV infection/AIDS who were referred from the ART Centre, Hassan, Karnataka, India. J. Clin. Diagn. Res. 6(10), 1756–1760 (2012).
   PubMedGoogle Scholar
• Wang Z, Jia R, Ge S et al. Ocular complications of human immunodeficiency virus infection in eastern China. Am. J. Ophthalmol. 153(2), 363–369.e1 (2012).
   PubMed Web of Science ®Google Scholar
• Lamichhane G, Shah D, Sharma S, Chaudhary M. Ocular manifestations in HIV/AIDS cases in Nepal. Nepal. J. Ophthalmol. 2(1), 45–50 (1970).
   Google Scholar
• Emina MO, Odjimogho SE. Ocular problems in HIV and AIDS patients in Nigeria. Optom. Vis. Sci. 87(12), 979–984 (2010).
   PubMed Web of Science ®Google Scholar
• Abdollahi A, Giv HB, Reza Z et al. Clinical spectrum of 15 patients with HIV-related ocular involvement in Tehran. Int. J. Ophthalmol. 3(4), 331–336 (2010).
   PubMed Web of Science ®Google Scholar
• Sahoo S. HIV- and AIDS-related ocular manifestations in Tanzanian patient. Malays. J. Med. Sci. 17(1), 12–16 (2010).
   PubMedGoogle Scholar
• Gharai S, Venkatesh P, Garg S, Sharma SK, Vohra R. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol. 15(4), 264–271 (2008).
   PubMed Web of Science ®Google Scholar
• Rodrigues ML, Rodrigues MDLV, Figueiredo JFDC, Freitas JAHD. Ocular problems in Brazilian patients with AIDS before and in highly active antiretroviral therapy (HAART) era. Braz. J. Infect. Dis. 11(2), 199–202 (2007).
   PubMed Web of Science ®Google Scholar
• Jabs DA, Van Natta ML, Holbrook JT et al. Longitudinal study of the ocular complications of AIDS. Ophthalmology 114(4), 780–786.e3 (2007).
   PubMed Web of Science ®Google Scholar
• Accorinti M, Pirraglia MP, Corradi R et al. Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART. Eur. J. Ophthalmol. 16(5), 728–732 (2006).
   PubMed Web of Science ®Google Scholar
• Biswas J, Madhavan HN, George AE et al. Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center. Am. J. Ophthalmol. 129(1), 9–15 (2000).
   PubMed Web of Science ®Google Scholar
• Hodge G. Ocular opportunistic infection incidences among patients who are HIV positive compared to patients who are HIV negative. Opthalmology 105(5), 895–900 (1998).
   PubMed Web of Science ®Google Scholar
• Maclean H, Hall AJ, McCombe MF, Sandland AM. AIDS and the eye. A 10-year experience. Aust. N. Z. J. Ophthalmol. 24(1), 61–67 (1996).
   PubMedGoogle Scholar
• Jabs DA. Ocular manifestation of HIV infection. Am. J. Ophthalmol. 121(1), 114–115 (1996).
   Google Scholar
• Wang Z-D, Wang S-C, Liu H-H et al. Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV 4(4), 177–188 (2017).
   PubMed Web of Science ®Google Scholar
• Rajapakse S, Weeratunga P, Rodrigo C et al. Prophylaxis of human toxoplasmosis: a systematic review. Pathog. Glob. Health 111(7), 333–342 (2017).
   PubMed Web of Science ®Google Scholar
• Fernandes Felix JP, Cavalcanti Lira RP, Grupenmacher AT et al. Long-term results of trimethoprim–sulfamethoxazole versus placebo to reduce the risk of recurrent Toxoplasma gondii retinochoroiditis. Am. J. Ophthalmol. 213, 195–202 (2020).
   PubMed Web of Science ®Google Scholar